Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2001
10/30/2001US6310176 Antimicrobially active polypeptides
10/30/2001US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6310056 2-substituted with a imidazo(5,1-b)thiazole group; treating infections, including antibiotic resistant bacterial infections
10/30/2001US6310055 Halophenoxy substituted carbapenem antibacterial compounds
10/30/2001US6310044 Oligonucleotide therapies for modulating the effects of herpesviruses
10/30/2001US6309866 6-phosphogluconate dehydrogenase
10/30/2001US6309819 Diagnostic and therapeutic system for Crohn's disease and Colitia ulcerosa
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001US6309651 A method of inhibiting, moderating or diagnosing pseudomonas aeruginosa infection is disclosed.
10/30/2001US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified.
10/30/2001US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host.
10/30/2001US6309647 The recombinant viruses and gene products therefrom are useful for eliciting protection against canine distemper virus and/or measles virus.
10/30/2001US6309632 For reducing hiv viral load and treating aids by administering granulocyte-macrophage colony stimulating factor (gm-csf).
10/30/2001CA2029863C Compositions and methods for treating viral infections
10/30/2001CA2025113C Agent for preventing infection with antibiotic-resistant staphylococcus
10/27/2001CA2345444A1 Novel therapeutic processes and useful compositions therefor
10/26/2001CA2304991A1 Synthetic gene of bovine viral diarrhoea virus
10/25/2001WO2001079540A2 Methods for measuring drug resistance
10/25/2001WO2001079524A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001WO2001079520A1 Hybrid glycosylated products and their production and use
10/25/2001WO2001079510A1 Materials and methods relating to immune responses to fusion proteins
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079469A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079299A1 Enhancement of antibody-mediated immune responses
10/25/2001WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079273A2 Viruses comprising mutated ion channel protein
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079269A2 Lipid binding protein 4
10/25/2001WO2001079259A1 Javelinization of protein antigens to heat shock proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079249A2 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them
10/25/2001WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001WO2001079216A2 Polyamide nucleic acid derivatives, agents and methods for producing them
10/25/2001WO2001079211A1 Process for the preparation of a 3-vinylcephem compound
10/25/2001WO2001079196A2 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079167A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001WO2001079156A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078789A2 Poliovirus replicons encoding therapeutic agents and uses thereof
10/25/2001WO2001078787A2 Lipopolysaccharide-conjugate vaccine for sepsis treatment
10/25/2001WO2001078776A1 Herpes virus complementing cell line
10/25/2001WO2001078775A2 A method for making an hiv vaccine
10/25/2001WO2001078774A2 Recombinant intracellular pathogen vaccines and methods for use
10/25/2001WO2001078773A2 Dissociated pili, their production and use
10/25/2001WO2001078772A1 Heat shock protein-based antiviral vaccines
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078767A2 Pharmaceutical preparations comprising modified peptides
10/25/2001WO2001078746A1 Respiratory compositions
10/25/2001WO2001078743A1 Medical combinations comprising tiotropium and mometasone
10/25/2001WO2001078742A1 Medical combination comprising salmeterol and budesonide
10/25/2001WO2001078738A1 Medical compositions comprising (r,r)-formoterol and rofleponide
10/25/2001WO2001078736A1 Medical combinations comprising tiotropium and rofleponide
10/25/2001WO2001078732A1 Ciprofloxacin infusion solutions having a good storage stability
10/25/2001WO2001078731A1 Ciprofloxacin infusion solutions with improved storage life
10/25/2001WO2001078719A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078700A2 Compositions for use in modulating immune system function comprising at least one retrinoid and at least one cytokine
10/25/2001WO2001078655A2 Methods and compositions for heat shock protein mediated immunotherapy of melanoma
10/25/2001WO2001078654A2 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078648A2 6-methylnicotinamide derivatives as antiviral agents
10/25/2001WO2001078533A2 Nutritional modules
10/25/2001WO2001040499A3 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses
10/25/2001WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001WO2001023597A3 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
10/25/2001WO2001023421A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
10/25/2001WO2001022993A3 MUCOSAL DTPa VACCINES
10/25/2001WO2001022950A3 Diosolane nucleoside analogs for the treatment or prevention of viral infection
10/25/2001WO2001012790A3 Isomerase proteins
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001WO2000056724A9 Oxazole and thiazole combinatorial libraries
10/25/2001WO2000047104A3 Antagonists of hmg1 for treating inflammatory conditions
10/25/2001WO2000040605A9 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/25/2001US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001US20010034358 Human immunodeficiency syndrone, hepatitis virus
10/25/2001US20010034353 Administering a mixture of antibiotic, nonsteroid antiinflammatory drug and a quinolone compound
10/25/2001US20010034341 Bactericides
10/25/2001US20010034340 Hormone replacement therapy
10/25/2001US20010034331 Isolated polypeptide
10/25/2001US20010034062 For engineering cells for delivery of antibodies to combat respiratory diseases, viral infection, asthma, allergy, and macular degeneration
10/25/2001US20010034042 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
10/25/2001US20010034032 Determining a subject's susceptibility to or the rapidity of progression of sepsis in a subject by detecting at least one allele of an Interleukin-1 proinflammatory haplotype in a nucleic acid sample which indicates increased susceptibility
10/25/2001US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
10/25/2001US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein
10/25/2001US20010033864 Low dose entecavir formulation and use
10/25/2001US20010033845 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
10/25/2001US20010033838 Animal derived lipid
10/25/2001US20010033834 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/25/2001DE10018783A1 Stable aqueous ciprofloxacin infusion solutions containing sulfuric acid as the stabilizing agent useful for the treatment of bacterial infections in humans and animals
10/25/2001DE10018781A1 Aqueous ciprofloxacin infusion solutions containing orthophosphoric acid monoester or diester as solubilizing and stabilizing agent useful for the treatment of bacterial infections
10/25/2001CA2747325A1 Albumin fusion proteins
10/25/2001CA2409190A1 Poliovirus replicons encoding therapeutic agents and uses thereof
10/25/2001CA2406475A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 1798